Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value

Core Insights - Danaher Corporation's shares reached the target price of $210 following a strong third-quarter report [1] Financial Performance - The third-quarter report indicated robust performance, contributing to the stock price reaching the target [1] Analyst Perspective - The analyst maintains a positive view on Danaher Corporation despite the stock reaching the target price [1]